drugset / Trial / NCT06969300

FMRF Combined With 30% SSA in the Treatment of Rosacea

NCT06969300

RandomizedParallel-groupDouble-blindTreatment

Summary

This study was a single-center, case-by-case, bilateral facial comparison study. A total of 15 patients were included. On the day of enrollment, after the completion of the test items, treatment was carried out (full face gold micro-needling + 30% salicylic acid on the half face), and on-site follow-up was conducted 1 week later, 2 weeks later follow-up was conducted and the second acid brushing treatment was performed, 4 weeks later follow-up was conducted and the third acid brushing treatment was performed, on-site follow-up was conducted at the 8th week and the 12th week, and the follow-up contents included: Visia photography, camera photography, non-invasive skin testing, questionnaire assessment, etc. The study duration was 12 weeks.

Timeline

Start
2023-12-01
Primary completion
2024-11-14
Completion
2024-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject salicylic acid Small molecule 30 % Topical

Indications